magnus grönberg – Page 7

Mandatory notification of trade – primary insider

ContextVision, Home, Investor News, News 2020-08-28

Ola Lindblad, VP Medical Imgaing of ContextVision, has on August 27, 2020 purchased 1,800 shares in ContextVision AB at an average price of NOK 22.37 per share. After the transaction, Mr Lindblad holds a total of 6,300 shares in ContextVision AB.

ContextVision – Mandatory notification of trade – primary insider

ContextVision, Home, Investor News, News 2020-08-17

STOCKHOLM – August 17, 2020 – Fredrik Palm, CEO of ContextVision, has on August 17, 2020 purchased 200 shares in ContextVision AB at an average price of NOK 245 per share. After the transaction, Mr Palm holds a total of 2,820 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 […]

ContextVision – key information relating to share split

ContextVision, Home, Investor News, News 2020-08-13

STOCKHOLM – Aug 13, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announces key information relating to the share spilt after a decision by the Board of Directors as of August 12th 2020. Reference is made to the extraordinary general meeting of ContextVision, held on August 5th, […]

ContextVision’s second quarter sees multiple product releases including digital pathology debut

Financial reports, Investor News, News 2020-08-13

ContextVision today reports a progressive second quarter. INIFY® Prostate Screening – the company’s first decision support tool in a planned digital pathology portfolio – was granted CE-mark status, paving the way for a strong entry into the fast-growing digital pathology market. In addition, the company continues to spearhead the image enhancement market with its new next-generation ultrasound product, Rivent®.

ContextVision Extraordinary General Meeting

ContextVision, Home, Investor News, News 2020-08-05

On the 5th of August 2020, ContextVision held an Extraordinary General Meeting in Stockholm. The Board’s proposal for adoption of new articles of association was approved The Board’s proposal for decision on the share split of the company’s share was approved No other matters were processed at the meeting. For further information, please contact:Ann-Charlotte Linderoth […]

ContextVision announces first CE marked digital pathology product

ContextVision, Digital Pathology, Home, Investor News, News 2020-06-29

ContextVision today announced that its first digital pathology product in a planned portfolio has been granted CE mark status. This means that INIFY® Prostate Screening is now available for routine clinical use within the European Union.

ContextVision – Invitation to Extraordinary General Meeting 2020

ContextVision, Home, Investor News, News 2020-06-24

ContextVision hereby invites shareholders to an Extraordinary General Meeting on August 5, 2020. Please find attached the invitation including agenda and details on how to register. Please contact: for any questions regarding the Extraordinary General Meeting.

ContextVision – Company presentation held at SpareBank 1 Markets Webinar

ContextVision, Home, Investor News, News 2020-06-12

Today ContextVision presented the company at a webinar arranged by SpareBank 1 Markets in Norway. CEO Fredrik Palm gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation will also be published on the company's website.

ContextVision Again Redefines Image Enhancement for Ultrasound

ContextVision, Home, News 2020-05-27

STOCKHOLM – May 27, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced the release of RiventTM, its seventh generation of image enhancement software for 2D ultrasound.

Mandatory notification of trade – primary insider

ContextVision, Home, Investor News, News 2020-05-19

Fredrik Palm, CEO of ContextVision, has on May 19, 2020 purchased 120 shares in ContextVision AB at an average price of NOK 155 per share. After the transaction, Mr Palm holds a total of 2620 shares in ContextVision AB.